Cargando…

An integrated multigene expression panel to predict long-term survival after curative hepatectomy in patients with hepatocellular carcinoma

Hepatocellular carcinoma (HCC) frequently recurs even after curative hepatectomy. To develop an integrated multigene expression panel, 144 patients were randomly assigned to either discovery or validation set in a 1:2 ratio. Using surgically resected HCC specimens, expression levels of 12 candidate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanda, Mitsuro, Murotani, Kenta, Sugimoto, Hiroyuki, Miwa, Takashi, Umeda, Shinichi, Suenaga, Masaya, Hayashi, Masamichi, Hattori, Norifumi, Tanaka, Chie, Kobayashi, Daisuke, Yamada, Suguru, Fujiwara, Michitaka, Kodera, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642618/ https://www.ncbi.nlm.nih.gov/pubmed/29050343 http://dx.doi.org/10.18632/oncotarget.20369

Ejemplares similares

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

A novel dual‐marker expression panel for easy and accurate risk stratification of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Expression of sushi domain containing two reflects the malignant potential of gastric cancer
por: Umeda, Shinichi, et al.
Publicado: (2018)

Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma
por: Umeda, Shinichi, et al.
Publicado: (2017)

Modified two‐dimensional response as surrogate marker of overall survival in patients with metastatic colorectal cancer
por: Nakayama, Goro, et al.
Publicado: (2016)

The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy
por: Shimizu, Dai, et al.
Publicado: (2017)

Perioperative and prognostic implication of albumin‐bilirubin‐TNM score in Child‐Pugh class A hepatocellular carcinoma
por: Sonohara, Fuminori, et al.
Publicado: (2018)

Hepatic metastasis of gastric cancer is associated with enhanced expression of ethanolamine kinase 2 via the p53–Bcl-2 intrinsic apoptosis pathway
por: Miwa, Takashi, et al.
Publicado: (2021)

Albumin-Bilirubin Score Predicts Tolerability to Adjuvant S-1 Monotherapy after Curative Gastrectomy
por: Miwa, Takashi, et al.
Publicado: (2019)

Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter
por: Yamada, Suguru, et al.
Publicado: (2016)

The significance of relative dose intensity in adjuvant chemotherapy of pancreatic ductal adenocarcinoma—including the analysis of clinicopathological factors influencing relative dose intensity
por: Yabusaki, Norimitsu, et al.
Publicado: (2016)

Aberrant expression of melanoma-associated antigen-D2 serves as a prognostic indicator of hepatocellular carcinoma outcome following curative hepatectomy
por: HASHIMOTO, RYOJI, et al.
Publicado: (2015)

Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer
por: Tanaka, Nobutake, et al.
Publicado: (2018)

A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage at the anastomotic site after esophagectomy
por: Kanda, Mitsuro, et al.
Publicado: (2020)

Multi‐institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2019)

Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2016)

Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complications after radical gastrectomy for clinical T2-4 gastric cancer
por: Inaoka, Kenichi, et al.
Publicado: (2017)

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)
por: Nakayama, Goro, et al.
Publicado: (2017)

Survival times are similar among patients with peritoneal, hematogenous, and nodal recurrences after curative resections for gastric cancer
por: Sawaki, Koichi, et al.
Publicado: (2020)

Identification of stromal cell-derived factor 4 as a liquid biopsy-based diagnostic marker in solid cancers
por: Shinozuka, Takahiro, et al.
Publicado: (2023)

Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment
por: Fujii, Tsutomu, et al.
Publicado: (2015)

A Multicenter Randomized Phase II Trial Investigating the Effect of Polyglycolic Acid Sheet on the Prevention of Pancreatic Fistula After Gastrectomy with Prophylactic Lymph Node Dissection
por: Shimizu, Dai, et al.
Publicado: (2023)

Prognostic significance of perioperative tumor marker levels in stage II/III gastric cancer
por: Suenaga, Yasuhito, et al.
Publicado: (2019)

Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2020)

Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2014)

Short-term outcomes after conventional transthoracic esophagectomy
por: Niwa, Yukiko, et al.
Publicado: (2016)

Phase II study of capecitabine plus oxaliplatin (CapOX) as adjuvant chemotherapy for locally advanced rectal cancer (CORONA II)
por: Hattori, Norifumi, et al.
Publicado: (2019)

Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2016)

Serosal Invasion Strongly Associated With Recurrence After Curative Hepatic Resection of Hepatocellular Carcinoma: A Retrospective Study of 214 Consecutive Cases
por: Sonohara, Fuminori, et al.
Publicado: (2015)

Expression of cellular retinoic acid binding protein 1 predicts peritoneal recurrence of gastric cancer
por: Sakata, Kazuki, et al.
Publicado: (2022)

Efficacy of enteral nutrients containing β-hydroxy-β-methylbutyrate, glutamine, and arginine for the patients with anastomotic leakage after gastrectomy: study protocol of a multicenter phase II clinical trial
por: Kanda, Mitsuro, et al.
Publicado: (2018)

A functional polymorphism in the epidermal growth factor gene predicts hepatocellular carcinoma risk in Japanese hepatitis C patients
por: Suenaga, Masaya, et al.
Publicado: (2013)

Dynamin 3: a new candidate tumor suppressor gene in hepatocellular carcinoma detected by triple combination array analysis
por: Inokawa, Yoshikuni, et al.
Publicado: (2013)

GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
por: Shimizu, Dai, et al.
Publicado: (2017)

Identification of a serum-based miRNA signature for response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy
por: Niwa, Yukiko, et al.
Publicado: (2019)

Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi‐institutional dataset
por: Nakagawa, Nobuhiko, et al.
Publicado: (2018)

Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis
por: Fujita, Keizo, et al.
Publicado: (2020)

Effectiveness of plasma treatment on pancreatic cancer cells
por: HATTORI, NORIFUMI, et al.
Publicado: (2015)

Identification of the collagen type 1 alpha 1 gene (COL1A1) as a candidate survival-related factor associated with hepatocellular carcinoma
por: Hayashi, Masamichi, et al.
Publicado: (2014)

Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial
por: Fujii, Tsutomu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_t7962al1k11rmo0g7gd6mrtju6